Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease

• Asıl Yazarlar: Hylemariam Mihiretie Mengist (Yazar), Daniel Mekonnen (Yazar), Ahmed Mohammed (Yazar), Ronghua Shi (Yazar), Tengchuan Jin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Effective, safe, and pharmacokinetically suitable drugs are urgently needed to curb the ongoing COVID-19 pandemic. The main protease or 3C-like protease (Mpro or 3CLpro) of SARS-CoV-2 is considered an important target to formulate potent drugs corresponding to its crucial role in virus replication a...